Literature DB >> 23891163

Macamides and their synthetic analogs: evaluation of in vitro FAAH inhibition.

Hui Wu1, Charles J Kelley, Alejandro Pino-Figueroa, Huyen D Vu, Timothy J Maher.   

Abstract

Maca (Lepidium meyenii), a traditional food crop of the Peruvian Andes is now widely touted as a dietary supplement. Among the various chemical constituents isolated from the plant are a unique series of non-polar, long-chain fatty acid N-benzylamides known as macamides. We have synthesized 11 of the 19 reported macamides and have tested each as potential inhibitors of the human enzyme, fatty acid amide hydrolase (FAAH). The five most potent macamides were FAAH inhibitors (IC50=10-17μM). These amides were derivatives of oleic, linoleic and linolenic acids and benzylamine or 3-methoxybenzylamine. Of the three compounds evaluated in a pre-incubation time study, two macamides were not irreversible inhibitors of FAAH. The third, a carbamate structurally related to macamides, was shown to be an irreversible inhibitor of FAAH (IC50=0.153μM).
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  3-Methoxybenzylamine; Anandamide; Carbamate; FAAH; Fatty acid amide; Lepidium meyenii; Maca; Macamide; OL-135; Oleamide; PF-750; Urea

Mesh:

Substances:

Year:  2013        PMID: 23891163     DOI: 10.1016/j.bmc.2013.06.034

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  9 in total

1.  Inhibition of Fatty Acid Amide Hydrolase (FAAH) by Macamides.

Authors:  M Alasmari; M Bӧhlke; C Kelley; T Maher; A Pino-Figueroa
Journal:  Mol Neurobiol       Date:  2018-06-20       Impact factor: 5.590

2.  Synthesis and biological screening of a library of macamides as TNF-α inhibitors.

Authors:  Víctor Tena Pérez; Luis Apaza Ticona; Andreea Madalina Serban; Javier Acero Gómez; Ángel Rumbero Sánchez
Journal:  RSC Med Chem       Date:  2020-08-06

3.  N-Benzyl-linoleamide, a Constituent of Lepidium meyenii (Maca), Is an Orally Bioavailable Soluble Epoxide Hydrolase Inhibitor That Alleviates Inflammatory Pain.

Authors:  Nalin Singh; Bogdan Barnych; Christophe Morisseau; Karen M Wagner; Debin Wan; Ashley Takeshita; Hoang Pham; Ting Xu; Abhaya Dandekar; Jun-Yan Liu; Bruce D Hammock
Journal:  J Nat Prod       Date:  2020-12-15       Impact factor: 4.050

4.  In silico profiling for secondary metabolites from Lepidium meyenii (maca) by the pharmacophore and ligand-shape-based joint approach.

Authors:  Fan Yi; Xiao-Lei Tan; Xin Yan; Hai-Bo Liu
Journal:  Chin Med       Date:  2016-09-26       Impact factor: 5.455

5.  Chemical profiling analysis of Maca using UHPLC-ESI-Orbitrap MS coupled with UHPLC-ESI-QqQ MS and the neuroprotective study on its active ingredients.

Authors:  Yanyan Zhou; Peng Li; Adelheid Brantner; Hongjie Wang; Xinbin Shu; Jian Yang; Nan Si; Lingyu Han; Haiyu Zhao; Baolin Bian
Journal:  Sci Rep       Date:  2017-03-17       Impact factor: 4.379

6.  Integrated Proteomics and Lipidomics Investigation of the Mechanism Underlying the Neuroprotective Effect of N-benzylhexadecanamide.

Authors:  Yanyan Zhou; Hongjie Wang; Feifei Guo; Nan Si; Adelheid Brantner; Jian Yang; Lingyu Han; Xiaolu Wei; Haiyu Zhao; Baolin Bian
Journal:  Molecules       Date:  2018-11-09       Impact factor: 4.411

7.  Optimization of Ultrasound-Assisted Extraction, HPLC and UHPLC-ESI-Q-TOF-MS/MS Analysis of Main Macamides and Macaenes from Maca (Cultivars of Lepidium meyenii Walp).

Authors:  Shu-Xiao Chen; Ke-Ke Li; Duoji Pubu; Si-Ping Jiang; Bin Chen; Li-Rong Chen; Zhen Yang; Chao Ma; Xiao-Jie Gong
Journal:  Molecules       Date:  2017-12-10       Impact factor: 4.411

Review 8.  Progress on the Chemical Constituents Derived from Glucosinolates in Maca (Lepidium meyenii).

Authors:  Yan-Jie Huang; Xing-Rong Peng; Ming-Hua Qiu
Journal:  Nat Prod Bioprospect       Date:  2018-08-27

9.  Protective effects of macamides from Lepidium meyenii Walp. against corticosterone-induced neurotoxicity in PC12 cells.

Authors:  Zejun Yu; Wenwen Jin; Yajie Cui; Mingzhang Ao; Hao Liu; Hang Xu; Longjiang Yu
Journal:  RSC Adv       Date:  2019-07-26       Impact factor: 4.036

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.